Annual report pursuant to Section 13 and 15(d)

Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.3.1.900
Nature of Operations and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
Cash and cash equivalents at the end of each period were as follows (in thousands):
 
 
December 31, 2015
 
December 31, 2014
Cash
$
47,431

 
$
37,314

Cash equivalents
57,483

 
7,502

Total cash and cash equivalents
$
104,914

 
$
44,816

Schedule of Earnings Per Share, Basic and Diluted
The following table illustrates the computation of basic and diluted income per share for the periods indicated (in thousands, except per share data):
 
Year Ended December 31,
 
2015
 
2014
 
Income
(Numerator)
 
Shares
(Denominator)
 
Per Share Amount
 
Income
(Numerator)
 
Shares
(Denominator)
 
Per Share Amount
Basic EPS:
 
 
 
 
 
 
 
 
 
 
 
Net income available to common stockholders
$
47,241

 
 

 
 

 
$
20,360

 
 

 
 

Less: undistributed earnings to participating securities

 
 

 
 

 
(127
)
 
 

 
 

Net income allocated to common stockholders
$
47,241

 
12,302

 
$
3.84

 
$
20,233

 
12,131

 
$
1.67

Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
Warrants to purchase common stock

 
21

 
 

 

 
421

 
 

Non-vested restricted stock

 
49

 
 

 

 
48

 
 

Plus: reallocation of undistributed earnings to participating securities

 
 

 
 

 
5

 
 

 
 

Diluted EPS:
 
 
 
 
 
 
 
 
 
 
 
Net income allocated to common stockholders plus assumed conversions
$
47,241

 
12,372

 
$
3.82

 
$
20,238

 
12,600

 
$
1.61

Available-for-sale Securities
Available-for-sale investments included in cash equivalents at the end of each period were as follows (in thousands):
 
December 31, 2015
 
December 31, 2014
 
Adjusted Cost
 
Gross Unrealized Gains/Losses
 
Fair Value
 
Adjusted Cost
 
Gross Unrealized Gains/Losses
 
Fair Value
Municipal bonds and notes
$
35,222

 
$
2

 
$
35,224

 
$

 
$

 
$

Corporate debt securities
5,029

 
(5
)
 
5,024

 

 

 

Financial institution instruments
17,235

 

 
17,235

 
7,502

 

 
7,502

Total available-for-sale investments
$
57,486

 
$
(3
)
 
$
57,483

 
$
7,502

 
$

 
$
7,502